ARTICLE | Clinical News
Phase III results for Estrasorb
March 13, 2001 8:00 AM UTC
Novavax (NOX) said that preliminary analysis of a double-blind, 200-patient U.S. Phase III study of its Estrasorb transdermal estrogen lotion in menopausal women showed a significant decrease in hot f...